GH
Price
$21.80
Change
-$0.00 (-0.00%)
Updated
Oct 3 closing price
26 days until earnings call
MASS
Price
$3.50
Change
+$0.02 (+0.57%)
Updated
Oct 4 closing price
26 days until earnings call
Ad is loading...

GH vs MASS

Header iconGH vs MASS Comparison
Open Charts GH vs MASSBanner chart's image
Guardant Health
Price$21.80
Change-$0.00 (-0.00%)
Volume$977.36K
CapitalizationN/A
908 Devices
Price$3.50
Change+$0.02 (+0.57%)
Volume$116.04K
CapitalizationN/A
View a ticker or compare two or three
GH vs MASS Comparison Chart
Loading...
MASS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
GH vs. MASS commentary
Oct 05, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GH is a Buy and MASS is a Hold.

COMPARISON
Comparison
Oct 05, 2024
Stock price -- (GH: $22.16 vs. MASS: $3.50)
Brand notoriety: GH: Notable vs. MASS: Not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: GH: 46% vs. MASS: 56%
Market capitalization -- GH: $2.46B vs. MASS: $227.41M
GH [@Medical Specialties] is valued at $2.46B. MASS’s [@Medical Specialties] market capitalization is $227.41M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GH’s FA Score shows that 0 FA rating(s) are green whileMASS’s FA Score has 1 green FA rating(s).

  • GH’s FA Score: 0 green, 5 red.
  • MASS’s FA Score: 1 green, 4 red.
According to our system of comparison, MASS is a better buy in the long-term than GH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MASS’s TA Score shows that 5 TA indicator(s) are bullish.

  • MASS’s TA Score: 5 bullish, 3 bearish.

Price Growth

GH (@Medical Specialties) experienced а -3.15% price change this week, while MASS (@Medical Specialties) price change was -3.58% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.13%. For the same industry, the average monthly price growth was +4.30%, and the average quarterly price growth was -3.02%.

Reported Earning Dates

GH is expected to report earnings on Oct 31, 2024.

MASS is expected to report earnings on Oct 31, 2024.

Industries' Descriptions

@Medical Specialties (-1.13% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GH($2.47B) has a higher market cap than MASS($227M). GH YTD gains are higher at: -18.078 vs. MASS (-68.806). MASS has higher annual earnings (EBITDA): -34.03M vs. GH (-433.3M). GH has more cash in the bank: 1.17B vs. MASS (146M). MASS has less debt than GH: MASS (5.95M) vs GH (1.35B). GH has higher revenues than MASS: GH (564M) vs MASS (50.2M).
GHMASSGH / MASS
Capitalization2.47B227M1,086%
EBITDA-433.3M-34.03M1,273%
Gain YTD-18.078-68.80626%
P/E RatioN/AN/A-
Revenue564M50.2M1,124%
Total Cash1.17B146M801%
Total Debt1.35B5.95M22,775%
FUNDAMENTALS RATINGS
GH: Fundamental Ratings
GH
OUTLOOK RATING
1..100
3
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MASS
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
77%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 1 day ago
78%
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
MASS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LICRX15.840.12
+0.76%
Lord Abbett International Equity R3
CNWAX85.050.63
+0.75%
American Funds New World 529A
FFECX15.390.10
+0.65%
Nuveen Dividend Value C
HRLSX9.240.02
+0.22%
Hartford Real Asset R4
MAPTX21.41N/A
N/A
Matthews Pacific Tiger Investor